About Tyche Industries Limited
Data last updated:
Tyche Industries Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 July 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN L72200TG1998PLC029809. Its GSTIN is 37AAECS1587K1ZW (Andhra Pradesh). It is a listed company as per MCA records. Its shares are listed on BSE: 532384.
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹10.25 Cr. It was formerly known as Siris Soft Private Limited. It is led by directors including Sandeep Gokaraju (Managing Director) and Vijaya Lakshmi Penumatsa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at H.No.C – 21/A Road No.9 Film Nagar Jubileehills, Hyderabad, Telangana, India.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹53.63 Cr, a decline of 18.1% compared to the previous year. For the same year it recorded a net profit of ₹6.93 Cr (net margin 12.9%) and EBITDA of ₹2.24 Cr (EBITDA margin 4.2%). The net worth stands at ₹140.48 Cr (up 2.8% YoY). Total assets are valued at ₹140.47 Cr (up 2.8% YoY).
The company has about 150 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Tyche Industries. As per MCA filings, the company has satisfied charges of ₹9.8 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending. The company has 16 deals on record (16 market trades); the latest was in October 2017. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Aalidhra Pharmachem Private Limited with revenue of ₹74.98 Cr. The company has 7 MSME Form 1 returns on record between 2019 and 2023, listing 19 overdue payments to 8 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tycheindustries.com.
Company details
CIN history
Tyche Industries has one previous CIN (Corporate Identification Number): L72200AP1998PLC029809. The current CIN is L72200TG1998PLC029809, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L72200TG1998PLC029809 | Current |
| L72200AP1998PLC029809 | Previous |
Contact details
Tyche Industries Limited's registered office is in Hyderabad, Telangana. Its website is tycheindustries.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No.C – 21/A Road No.9 Film Nagar Jubileehills, Hyderabad, Telangana, India
- IndustryPharma, API Manufacturers
To see the full contact details of Tyche Industries Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Tyche Industries operates one associated brand: Tyche Industries. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company that manufactures and supplies bulk drug intermediates and advanced intermediates | tycheindustries.net |
Business activity
The main business activity of Tyche Industries is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tyche Industries Limited, buy the company report.
Financials of Tyche Industries Limited
FY 2025-26 filings availableTyche Industries Limited reported revenue of ₹53.63 Cr (down 18.1% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 53.63 | 65.47 | 69.51 | 75.39 | 62.27 | 78.24 | 73.70 |
| Revenue growth | -18.1% | -5.8% | -7.8% | +21.1% | -20.4% | +6.2% | - |
| EBITDA | 2.24 | 11.30 | 12.65 | 16.03 | 9.30 | 23.73 | 21.38 |
| EBITDA margin | +4.2% | +17.3% | +18.2% | +21.3% | +14.9% | +30.3% | +29.0% |
| Profit before tax | 9.46 | 16.73 | 16.63 | 19.09 | 12.62 | 26.74 | 23.32 |
| Net profit | 6.93 | 12.40 | 12.24 | 14.27 | 9.83 | 20.73 | 17.54 |
| Net profit margin | +12.9% | +18.9% | +17.6% | +18.9% | +15.8% | +26.5% | +23.8% |
| EPS (₹) | 6.77 | 12.12 | 11.95 | 13.83 | 9.11 | 19.51 | 17.14 |
| Balance sheet | |||||||
| Total assets | 140 | 137 | 127 | 119 | 106 | 97.71 | 78.64 |
| Net worth | 140 | 137 | 127 | 117 | 104 | 95.97 | 77.18 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 75.32 | 84.49 | 78.89 | 69.28 | 67.51 | 60.79 | 44.67 |
| Net working capital | 101 | 111 | 106 | 95.87 | 88.19 | 78.52 | 60.26 |
| Cash flow | |||||||
| Cash from operations | 2.85 | 8.54 | 7.71 | 6.43 | 4.46 | 15.45 | 15.21 |
| Cash from investing | (8.95) | (0.39) | 3.94 | (3.12) | 3.16 | 0.42 | 2.04 |
| Cash from financing | (3.07) | (2.56) | (2.05) | (1.54) | (1.02) | (1.02) | (0.62) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.10 | 16.20 | 10.58 | 14.16 | 12.70 | 12.37 | 17.75 | 20.54 |
| Revenue growth (YoY) | -28.4% | +31.0% | -40.4% | -31.1% | -18.2% | - | - | - |
| Other income | 2.26 | 2.96 | 1.85 | 2.65 | 1.77 | 2.01 | 2.04 | 1.84 |
| Total expenses | 10.80 | 16.86 | 9.49 | 14.29 | 10.75 | 12.54 | 12.92 | 16.52 |
| EBITDA | (1.70) | (0.66) | 1.09 | (0.13) | 1.95 | (0.17) | 4.83 | 4.02 |
| EBITDA margin | -18.7% | -4.1% | +10.3% | -0.9% | +15.4% | -1.4% | +27.2% | +19.6% |
| Depreciation | 0.62 | 0.59 | 0.48 | 0.47 | 0.45 | 0.50 | 0.50 | 0.49 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.06) | 1.71 | 2.46 | 2.05 | 3.27 | 1.34 | 6.37 | 5.37 |
| Tax | (0.01) | 0.54 | 0.64 | 0.53 | 0.83 | 0.38 | 1.64 | 1.37 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.10 | 16.20 | 10.58 | 14.16 | 12.70 | 12.37 | 17.75 | 20.54 |
| Revenue growth (YoY) | -28.4% | +31.0% | -40.4% | -31.1% | -18.2% | - | - | - |
| Other income | 2.26 | 2.96 | 1.85 | 2.65 | 1.77 | 2.01 | 2.04 | 1.84 |
| Total expenses | 10.80 | 16.86 | 9.49 | 14.29 | 10.75 | 12.54 | 12.92 | 16.52 |
| EBITDA | (1.70) | (0.66) | 1.09 | (0.13) | 1.95 | (0.17) | 4.83 | 4.02 |
| EBITDA margin | -18.7% | -4.1% | +10.3% | -0.9% | +15.4% | -1.4% | +27.2% | +19.6% |
| Depreciation | 0.62 | 0.59 | 0.48 | 0.47 | 0.45 | 0.50 | 0.50 | 0.49 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.06) | 1.71 | 2.46 | 2.05 | 3.27 | 1.34 | 6.37 | 5.37 |
| Tax | (0.01) | 0.54 | 0.64 | 0.53 | 0.83 | 0.38 | 1.64 | 1.37 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 53.63 | 65.47 | 69.51 | 75.39 | 62.27 | 78.24 | 73.70 |
| Revenue growth | -18.1% | -5.8% | -7.8% | +21.1% | -20.4% | +6.2% | - |
| Other income | 9.22 | 7.42 | 5.92 | 4.83 | 5.11 | 4.74 | 3.68 |
| Total expenses | 51.39 | 54.17 | 56.86 | 59.36 | 52.97 | 54.51 | 52.32 |
| Employee cost | 8.60 | 7.88 | 7.81 | 6.96 | 6.68 | 6.55 | 7.20 |
| EBITDA | 2.24 | 11.30 | 12.65 | 16.03 | 9.30 | 23.73 | 21.38 |
| EBITDA margin | +4.2% | +17.3% | +18.2% | +21.3% | +14.9% | +30.3% | +29.0% |
| Depreciation | 2.00 | 1.99 | 1.94 | 1.77 | 1.79 | 1.72 | 1.74 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Profit before tax | 9.46 | 16.73 | 16.63 | 19.09 | 12.62 | 26.74 | 23.32 |
| Tax | 2.53 | 4.30 | 4.39 | 4.91 | 3.30 | 6.75 | 5.77 |
| Net profit | 6.93 | 12.40 | 12.24 | 14.27 | 9.83 | 20.73 | 17.54 |
| Net profit margin | +12.9% | +18.9% | +17.6% | +18.9% | +15.8% | +26.5% | +23.8% |
| EPS (₹) | 6.77 | 12.12 | 11.95 | 13.83 | 9.11 | 19.51 | 17.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
| Reserves & surplus | 130 | 126 | 116 | 107 | 93.97 | 85.72 | 66.93 |
| Shareholders' funds (net worth) | 140 | 137 | 127 | 117 | 104 | 95.97 | 77.18 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 140 | 137 | 127 | 119 | 106 | 97.71 | 78.64 |
| Assets | |||||||
| Gross block | 49.45 | 45.13 | 44.73 | 41.51 | 39.75 | 40.40 | 38.42 |
| Net block | 18.88 | 16.48 | 17.90 | 16.61 | 16.63 | 17.93 | 17.67 |
| Capital work in progress | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.53 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 9.92 | 16.64 | 12.56 | 17.97 | 11.24 | 10.95 | 9.56 |
| Sundry debtors | 19.54 | 17.12 | 19.12 | 22.08 | 16.42 | 17.13 | 12.93 |
| Cash & bank balances | 75.32 | 84.49 | 78.89 | 69.28 | 67.51 | 60.79 | 44.67 |
| Loans & advances | 3.16 | 2.69 | 2.48 | 3.11 | 5.85 | 7.44 | 7.72 |
| Total current assets | 108 | 121 | 113 | 112 | 101 | 96.31 | 74.88 |
| Total current liabilities | 6.56 | 9.62 | 6.68 | 16.57 | 12.83 | 17.79 | 14.62 |
| Net working capital | 101 | 111 | 106 | 95.87 | 88.19 | 78.52 | 60.26 |
| Total assets | 140 | 137 | 127 | 119 | 106 | 97.71 | 78.64 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 84.49 | 78.89 | 69.28 | 67.51 | 60.92 | 46.07 | 29.30 |
| Net cash from operating activities | 2.85 | 8.54 | 7.71 | 6.43 | 4.46 | 15.45 | 15.21 |
| Net cash from investing activities | (8.95) | (0.39) | 3.94 | (3.12) | 3.16 | 0.42 | 2.04 |
| Net cash from financing activities | (3.07) | (2.56) | (2.05) | (1.54) | (1.02) | (1.02) | (0.62) |
| Net change in cash | (9.17) | 5.59 | 9.61 | 1.77 | 6.59 | 14.85 | 16.63 |
| Closing cash | 75.32 | 84.49 | 78.89 | 69.28 | 67.51 | 60.79 | 44.67 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -18.1% | -5.8% | -7.8% | +21.1% | -20.4% | +6.2% | - |
| EBITDA growth | -80.2% | -10.7% | -21.1% | +72.4% | -60.8% | +11.0% | - |
| PBT growth | -43.5% | +0.6% | -12.9% | +51.3% | -52.8% | +14.7% | +136.8% |
| Net income growth | -44.1% | +1.3% | -14.2% | +45.2% | -52.6% | +18.2% | - |
| Revenue CAGR (3Y) | -10.7% | +1.7% | -3.9% | +0.8% | +4.9% | +14.9% | +20.0% |
| EBITDA CAGR (3Y) | -48.1% | +6.7% | -18.9% | -9.2% | +0.5% | +38.0% | +52.8% |
| Profitability & leverage | |||||||
| Net income margin | +12.9% | +19.0% | +17.6% | +18.8% | +15.0% | +25.6% | +23.8% |
| Return on capital employed | +6.8% | +12.7% | +13.5% | +17.0% | +12.4% | +30.3% | +33.2% |
| Return on net worth | +5.0% | +9.4% | +10.1% | +12.8% | +9.3% | +23.1% | +25.6% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.13 | 1.46 | 1.61 | 1.86 | 1.55 | 1.99 | 1.92 |
| Inventory turnover | 4.04 | 4.48 | 4.55 | 5.16 | 5.61 | 7.63 | 8.40 |
| Debtors turnover | 2.93 | 3.61 | 3.37 | 3.92 | 3.71 | 5.21 | 6.38 |
| EPS (₹) | 6.77 | 12.12 | 11.95 | 13.83 | 9.11 | 19.51 | 17.14 |
| Dividend per share (₹) | 3.50 | 3.00 | 2.50 | 0.00 | 1.50 | 1.00 | 0.00 |
| Book value per share (₹) | 137.11 | 133.43 | 123.70 | 113.96 | 101.72 | 93.66 | 75.32 |
To see the full year-wise statements and ratios of Tyche Industries Limited, buy the company report.
Board of directors of Tyche Industries Limited
Tyche Industries has 7 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijaya Lakshmi Penumatsa | Director | 11 Aug 2014 | 12 Years 2 Months | Current |
| Ganesh Kumar Gokaraju Also directs: Siris Agro Limited, Sri Indra Distillery Private Limited, Plutus Techlabs Private Limited and 3 more | Director | 14 Nov 1998 | 27 Years 11 Months | Current |
| Sai Sudhakar Panchakarla | Director | 25 Mar 2019 | 7 Years 7 Months | Current |
| Sandeep Gokaraju | Managing Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Venkataraju Gupta Kollepalli | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Satya Srinivas Uppalapati | Director | 05 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Tyche Industries Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aalidhra Pharmachem Private Limited | ₹74.98 Cr (FY 2024) | -16.0% | Surat, Gujarat, India | |||
| Seutic Labs Private Limited | ₹74.85 Cr (FY 2025) | -28.0% | Hyderabad, Telangana, India | |||
| Hoster Labs Private Limited | ₹74.69 Cr (FY 2024) | 0.0% | Hyderabad, Telangana, India | |||
| Sreepathi Pharmaceuticals Limited | ₹74.26 Cr (FY 2025) | -17.0% | Telangana, India | |||
| Apister Lifesciences Private Limited | ₹73.56 Cr (FY 2025) | -31.0% | Ahmedabad, Gujarat, India | |||
| Lavender Laboratories Private Limited | ₹72.29 Cr (FY 2025) | 29.0% | Pune, Maharashtra, India | |||
| S R Laboratories Private Limited | ₹72.1 Cr (FY 2025) | 22.0% | Telangana, India | |||
| Pellets Pharma Limited | ₹72.09 Cr (FY 2024) | 2.0% | Hyderabad, Telangana, India | |||
| Chemcrux Enterprises Limited | ₹71.5 Cr (FY 2025) | -10.0% | Vadodara, Gujarat, India | |||
| Nico Orgo Marketing Private Limited | ₹70.53 Cr (FY 2024) | -50.0% | Kheda, Gujarat, India | |||
| Tyche Industries Limitedthis company | ₹53.63 Cr (FY 2026) | ₹6.93 Cr | 12.9% | -18.1% | 150 | Hyderabad, Telangana, India |
To see the full peer comparison of Tyche Industries Limited, buy the company report.
Auditor
Tyche Industries Limited is audited by P S N RAVI SHANKER for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P S N RAVI SHANKER | FY 2023 | 003228S |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 62.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 38.00%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 62.00% | 62.00% | 62.00% | 62.00% |
| Public | 38.00% | 38.00% | 38.00% | 38.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Oct 2013 | 10459946 | Bank of India | ₹2.5 Cr | Satisfied | |
| 14 Mar 2009 | 10159085 | Others | ₹5 Cr | Satisfied | |
| 07 Sep 2000 | 90129875 | Uco Bank | ₹1.5 Cr | Satisfied | |
| 03 Dec 1999 | 80052147 | Uco Bank | ₹80 Lakh | Satisfied |
To see the full charge records of Tyche Industries Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Tyche Industries Limited has 16 deals on record (16 market trades); the latest was in October 2017.
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2017 | Market trade | ₹1.46 Cr | Buyer: Garnet International Limited |
| Jun 2010 | Market trade | ₹17.8 Lakh | Buyer: an individual Seller: Kostub Investment Limited |
| Mar 2010 | Market trade | ₹17 Lakh | Buyer: Kostub Investment Limited Seller: an individual |
| Dec 2009 | Market trade | ₹18.5 Lakh | Buyer: an individual Seller: Kostub Investment Limited |
| Dec 2007 | Market trade | ₹52.5 Lakh | Seller: Sun Investment and Trading Private Limited |
To see the full deal history of Tyche Industries Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Tyche Industries Limited has 2 court cases on record: 2 filed by Tyche Industries. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against State of Andhra Pradesh, and 2 others | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh | Disposed |
To see the full case history of Tyche Industries Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Tyche Industries Limited was last rated by Icra on 11 Jul 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 11 Jul 2018 |
To see the full credit ratings and regulatory alerts of Tyche Industries Limited, buy the company report.
MSME payment delays
Tyche Industries Limited has 7 MSME Form 1 returns on record between 2019 and 2023, listing 19 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Teena Bio Labs Private Limited | |||
| Saphire Scientific Co | |||
| Rolon Seals | |||
| GVR Enterprises | |||
| Lotus Granges (India) Private Limited |
To see the full MSME payment records of Tyche Industries Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Tyche Industries Limited has a workforce of 150 employees on its EPFO records as of Mar 31, 2024, across 2 active EPFO establishments.
GST
Tyche Industries has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAECS1587K1ZW | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Tyche Industries Limited, buy the company report.
Recent activity
Tyche Industries Limited has 23 board changes on record since 1998: 15 appointments and 8 cessations. The latest: Satya Srinivas Uppalapati was appointed as Director on 05 Sep 2025.
23 earlier events are in the company report.
News
Frequently asked questions
Tyche Industries is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 23 July 1998 (28+ years old) and is registered under CIN L72200TG1998PLC029809. Listed on BSE: 532384.
Tyche Industries reported revenue of ₹53.63 Cr for FY 2025-26 (down 18.1% YoY) based on standalone financials.
Tyche Industries has 7 current directors:
- Sandeep Gokaraju - Managing Director
- Vijaya Lakshmi Penumatsa - Director
- Ganesh Kumar Gokaraju - Director
- Sai Sudhakar Panchakarla - Director
- Venkataraju Gupta Kollepalli - Director
- Satya Srinivas Uppalapati - Director
- Srinivas Gelli - Director
The latest financial statements of Tyche Industries on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Tyche Industries is 37AAECS1587K1ZW, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Tyche Industries is L72200TG1998PLC029809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Tyche Industries is a listed company as per MCA records. Its shares are listed on BSE (code: 532384).
Tyche Industries has 2 court cases on record: 2 filed by the company. 1 is pending.
Tyche Industries was incorporated on 23 July 1998, making it 28+ years old. It is registered with the Registrar of Companies, Hyderabad.
Tyche Industries has 16 deals on record (16 market trades); the latest was in October 2017.
The peers of Tyche Industries by revenue are Aalidhra Pharmachem Private Limited, Seutic Labs Private Limited, Hoster Labs Private Limited, Sreepathi Pharmaceuticals Limited, Apister Lifesciences Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Satya Srinivas Uppalapati was appointed as Director on 05 Sep 2025. Eshwar Boosa ceased to be Director on 11 Sep 2023. Srinivas Gelli was appointed as Director on 01 Aug 2023. Tyche Industries has 23 board changes on record in total.